Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both normal development and also in response to treatment. The large variations observed in control group tumors can obscure detection of significant therapeutic effects due to the ambiguity in attributing causes of change. This can hinder development of effective therapies due to limitations in experimental design, rather than due to therapeutic failure. An improved method to model biological variation and heterogeneity in imaging signals is described. Specifically, Linear Poisson modelling (LPM) evaluates changes in apparent diffusion co-efficient (ADC) before and 72 hours after radiotherapy, in two xenograft models of colorectal cancer. The statistical significance of measured changes are compared to those attainable using a conventional t-test analysis on basic ADC distribution parameters. When LPMs were applied to treated tumors, the LPMs detected highly significant changes. The analyses were significant for all tumors, equating to a gain in power of 4 fold (i.e. equivelent to having a sample size 16 times larger), compared with the conventional approach. In contrast, highly significant changes are only detected at a cohort level using t-tests, restricting their potential use within personalised medicine and increasing the number of animals required during testing. Furthermore, LPM enabled the relative volumes of responding and non-responding tissue to be estimated for each xenograft model. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers, raising confidence in LPM data at clinically relevant sample sizes.
Deep learning-based assessment of tumor-associated stroma for diagnosing breast cancer in histopathology images
Radboud University Medical Center(拉德堡德大学医学中心);Beth Israel Deaconess Medical Center(贝斯以色列女执事医疗中心);Harvard Medical School(哈佛医学院);National Cancer Institute(美国国家癌症研究所);The Harker School(哈克学校);Mayo Clinic(梅奥诊所)
Medical World Model: Generative Simulation of Tumor Evolution for Treatment Planning
The Hong Kong University of Science and Technology (Guangzhou)(香港科技大学(广州));Johns Hopkins University(约翰霍普金斯大学);The First Affiliated Hospital of Nanjing Medical University(南京医科大学第一附属医院);University of California, San Francisco(加州大学旧金山分校)
本文提出医学世界模型 MeWM,结合视觉-语言策略模型与肿瘤生成动力学模型模拟治疗后肿瘤演化,并通过逆动力学模型优化个体化治疗方案,将最优 TACE 方案选择的 F1 分数提升 13%。
Treatment-aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction
Oslo University Hospital(奥斯陆大学医院);Universitat Politècnica de València(瓦伦西亚理工大学);Instituto Universitario de Tecnologías de la Información y Comunicaciones(信息技术与通信大学学院)
Improving utility of brain tumor confocal laser endomicroscopy: objective value assessment and diagnostic frame detection with convolutional neural networks
Arizona State University(亚利桑那州立大学);Irkutsk State Medical University(伊尔库茨克国立医科大学)
Lymphoid Infiltration Assessment of the Tumor Margins in H&E Slides
Laboratoire d’Informatique Paris Descartes (LIPADE)(巴黎笛卡尔大学计算机实验室(LIPADE));Université Paris Cité(巴黎大学);University of Applied Sciences of Western Switzerland (HES-SO Valais)(瑞士西部应用科学大学(瓦莱州));Ambroise-Paré Hospital(昂布鲁瓦兹-帕雷医院)
Predicting breast tumor proliferation from whole-slide images: the TUPAC16 challenge
Eindhoven University of Technology(埃因霍温理工大学);Beth Israel Deaconess Medical Center(贝斯以色列女执事医疗中心);Harvard Medical School(哈佛医学院);University Medical Center Utrecht(乌得勒支大学医学中心);Radboud University Medical Center(拉德堡德大学医学中心);Stanford University School of Medicine(斯坦福大学医学院);University of Heidelberg(海德堡大学);BIOQUANT;IPMB;DKFZ(德国癌症研究中心);The Harker School(哈克学校);ContextVision AB(ContextVision公司);IBM Research Zürich(IBM苏黎世研究院);IBM Research Brazil(IBM巴西研究院);United Institute of Informatics(联合信息学研究所);University of South Florida(南佛罗里达大学);University of Warwick(华威大学);Sectra(Sectra公司);Lunit Inc.(Lunit公司);Tsinghua University(清华大学);Microsoft Research(微软研究院);Beihang University(北京航空航天大学)
Automating tumor-infiltrating lymphocyte assessment in breast cancer histopathology images using QuPath: a transparent and accessible machine learning pipeline
UiT The Arctic University of Norway(挪威北极圈大学);University Hospital of North Norway(挪威北部大学医院)
Novel Radiomic Measurements of Tumor- Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Case Western Reserve University(凯斯西储大学);Picture Health(Picture Health公司);Stony Brook University(石溪大学);University Hospitals Cleveland Medical Center(克利夫兰大学医院医学中心);Yale School of Medicine(耶鲁医学院);The Cleveland Clinic Foundation (CCF)(克利夫兰诊所基金会(CCF));New York University (NYU) Langone Medical Center(纽约大学(NYU)朗格尼医学中心);Louis Stokes Cleveland Veterans Medical Center(路易斯·斯托克斯克利夫兰退伍军人医学中心)
目的:肿瘤相关血管系统与健康血管的不同之处在于其混乱的结构和扭曲性,这会促进治疗抵抗。这些属性的可测量差异可能有助于根据全身治疗(例如化疗)的可能获益对患者进行分层。在这项工作中,我们提出了一类新的放射性生物标志物,称为定量肿瘤相关血管系统(QuanTAV)特征,并证明了它们预测多种癌症,成像方式和治疗方案的反应和生存的能力。实验设计:我们对558名患者的常规治疗前放射学(CT或对比增强MRI)进行了肿瘤血管分割并计算了扭曲和组织的数学测量值,这些患者接受了乳腺癌(n=371)或非小细胞肺癌(NSCLC,n=187)的四种一线化疗治疗干预策略之一。结果如下:在4种基于化疗的治疗策略中,QuanTAV测量的分类器显著(p<0.05)预测了单独保持测试队列的反应(AUC=0.63-0.71),并且当添加到单独的重要临床变量模型中时,AUC增加了0.06-0.12。QuanTAV风险评分是乳腺癌化疗(p=0.002,HR=1.25,95% CI 1.08-1.44,C指数= 0.66)和NSCLC放化疗(p=0.039,HR=1.28,95% CI 1.01-1.62,C指数=0.66)治疗队列中无复发生存期的预后指标。在所有治疗组中,包括接受化疗的NSCLC患者(p=0.034,HR=2.29,95% CI 1.07-4.94,C指数=0.62),分类QuanTAV风险组具有独立预后。…
The Segment Anything foundation model achieves favorable brain tumor autosegmentation accuracy on MRI to support radiotherapy treatment planning
Universitätsklinikum Erlangen(埃尔兰根大学医院);Friedrich-Alexander-Universität Erlangen-Nürnberg(埃尔朗根-纽伦堡弗里德里希·亚历山大大学);Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN)(埃尔兰根-欧洲分子神经科学网络综合癌症中心)
Deep learning automates bidimensional and volumetric tumor burden measurement from MRI in pre- and post-operative glioblastoma patients
Future Processing Healthcare(未来医疗处理公司);Silesian University of Technology(西里西亚工业大学);Medical University of Silesia in Katowice(卡托维兹西里西亚医科大学);ZSM Chorzów(霍茹夫ZSM医院);University Clinical Centre(大学临床中心);Roche Pharmaceutical Research & Early Development(罗氏制药研究与早期开发部)
To deform or not: treatment-aware longitudinal registration for breast DCE-MRI during neoadjuvant chemotherapy via unsupervised keypoints detection
Radboud University Medical Centre(拉德堡德大学医学中心);The Netherlands Cancer Institute(荷兰癌症研究所);Macao Polytechnic University(澳门理工大学);Maastricht University Medical Centre(马斯特里赫特大学医学中心)
Deep Learning for Brain Tumor Segmentation in Radiosurgery: Prospective Clinical Evaluation
Skolkovo Institute of Science and Technology(斯科尔科沃科学技术学院);Kharkevich Institute for Information Transmission Problems(哈尔克维奇信息传输问题研究所);Moscow Institute of Physics and Technology(莫斯科物理技术学院);Moscow Gamma-Knife Center(莫斯科伽马刀中心);Burdenko Neurosurgery Institute(布尔坚科神经外科研究所)
Towards a deep learning approach for classifying treatment response in glioblastomas
Institute for Systems and Robotics - Lisbon and Department of Bioengineering of Instituto Superior Técnico(系统与机器人研究所 - 里斯本及 Instituto Superior Técnico 生物工程系);Hospital da Luz Learning Health(Luz医院学习健康中心);Imaging Department, Hospital da Luz(Luz医院影像部门)
Hybrid Multihead Attentive Unet-3D for Brain Tumor Segmentation
University of Engineering and Technology, Lahore(拉合尔工程技术大学);School of Interdisciplinary Engineering and Sciences, National University of Sciences and Technology(国家科技大学跨学科工程与科学学院)